Global Markets
Novartis waves goodbye to biosimilars with Sandoz split
Deal MakingNovartis waves goodbye to biosimilars with Sandoz splitNovartis waves goodbye to biosimilars with Sandoz split
Novartis will spin-off its generics division Sandoz, which includes a portfolio of eight biosimilar products.